Automation vs. Compliance: Managing FDA Risks in Digital Systems
In the life sciences, automation promises unprecedented efficiency and precision. However, every digital system introduces a new landscape of regulatory challenges. This article provides a comprehensive guide to identifying and managing the top FDA compliance risks in automation. From the complexities of software validation and data integrity under 21 CFR Part 11 to the rise of AI and the shift toward Computer Software Assurance (CSA), we provide a framework for ensuring your technology is an asset, not a liability.